Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02455297
Title Phase IIa Study of Copanlisib in Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Baltimore Maryland 21287 United States Details
Hackensack New Jersey 07601 United States Details
New York New York 10021 United States Details
New York New York 10029 United States Details
Burlington Vermont 05401 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field